Literature DB >> 17428841

Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?

Werner J H Koopman1, Sjoerd Verkaart, Henk Jan Visch, Sjenet van Emst-de Vries, Leo G J Nijtmans, Jan A M Smeitink, Peter H G M Willems.   

Abstract

Malfunction of NADH:ubiquinone oxidoreductase or complex I (CI), the first and largest complex of the mitochondrial oxidative phosphorylation system, has been implicated in a wide variety of human disorders. To demonstrate a quantitative relationship between CI amount and activity and mitochondrial shape and cellular reactive oxygen species (ROS) levels, we recently combined native electrophoresis and confocal and video microscopy of dermal fibroblasts of healthy control subjects and children with isolated CI deficiency. Individual mitochondria appeared fragmented and/or less branched in patient fibroblasts with a severely reduced CI amount and activity (class I), whereas patient cells in which these latter parameters were only moderately reduced displayed a normal mitochondrial morphology (class II). Moreover, cellular ROS levels were significantly more increased in class I compared with class II cells. We propose a mechanism in which a mutation-induced decrease in the cellular amount and activity of CI leads to enhanced ROS levels, which, in turn, induce mitochondrial fragmentation when not appropriately counterbalanced by the cell's antioxidant defense systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428841     DOI: 10.1152/ajpcell.00194.2006

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  36 in total

Review 1.  Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies.

Authors:  Fatima Djouadi; Jean Bastin
Journal:  Cells       Date:  2019-03-28       Impact factor: 6.600

2.  Mitochondria impairment correlates with increased sensitivity of aging RPE cells to oxidative stress.

Authors:  Yuan He; Jian Ge; Janice M Burke; Roland L Myers; Zhi Z Dong; Joyce Tombran-Tink
Journal:  J Ocul Biol Dis Infor       Date:  2011-07-26

Review 3.  Mitochondrial Morphofunction in Mammalian Cells.

Authors:  Elianne P Bulthuis; Merel J W Adjobo-Hermans; Peter H G M Willems; Werner J H Koopman
Journal:  Antioxid Redox Signal       Date:  2018-11-29       Impact factor: 8.401

4.  Functional Effects of Cigarette Smoke-Induced Changes in Airway Smooth Muscle Mitochondrial Morphology.

Authors:  Bharathi Aravamudan; Michael Thompson; Gary C Sieck; Robert Vassallo; Christina M Pabelick; Y S Prakash
Journal:  J Cell Physiol       Date:  2016-09-21       Impact factor: 6.384

Review 5.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

6.  ATP13A2 regulates mitochondrial bioenergetics through macroautophagy.

Authors:  Aaron M Gusdon; Jianhui Zhu; Bennett Van Houten; Charleen T Chu
Journal:  Neurobiol Dis       Date:  2011-12-13       Impact factor: 5.996

7.  Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency.

Authors:  Taj D King; Buffie Clodfelder-Miller; Keri A Barksdale; Gautam N Bijur
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

8.  Biochemical and mechanical dysfunction in a mouse model of desmin-related myopathy.

Authors:  Alina Maloyan; Hanna Osinska; Jan Lammerding; Richard T Lee; Oscar H Cingolani; David A Kass; John N Lorenz; Jeffrey Robbins
Journal:  Circ Res       Date:  2009-03-19       Impact factor: 17.367

Review 9.  Relevance of mitochondrial genetics and metabolism in cancer development.

Authors:  Giuseppe Gasparre; Anna Maria Porcelli; Giorgio Lenaz; Giovanni Romeo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

10.  The antioxidant Trolox restores mitochondrial membrane potential and Ca2+ -stimulated ATP production in human complex I deficiency.

Authors:  Felix Distelmaier; Henk-Jan Visch; Jan A M Smeitink; Ertan Mayatepek; Werner J H Koopman; Peter H G M Willems
Journal:  J Mol Med (Berl)       Date:  2009-03-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.